drugset / Trial / NCT04950790
Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind, placebo-parallel-controlled multiplier designed to observe and evaluate the efficacy and safety of Shuxuening injection in the treatment of acute ischemic stroke for 10 days and continue follow-up to 90 days after the onset of the disease.
Timeline
- Start
- 2018-04-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Shuxuening | Unknown | 20 ml | Intravenous |
| Background | Aspirin | Small molecule | — | Oral |
| Background | Clopidogrel | Small molecule | — | — |